Selective agonists reveal α1A‐ and α1B‐adrenoceptor subtypes in caudal artery of the young rat

Multiple alpha(1)-adrenoceptors were evaluated in caudal artery of the young Wistar rat using selective agonists and antagonists. Arteries were exposed to the selective alpha(1A)-adrenoceptor agonist, A-61603 (N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl] methanesulfonamide) or to phenylephrine and to prazosin (alpha(1)-adrenoceptor antagonist), or the selective alpha(1A)-adrenoceptor antagonists 5-methylurapidil, RS 100329 (5-methyl-3-[3-[4-[2-(2,2,2,-trifluoroethoxy)phenyl]-1-piperazinyl]propyl]-2,4-(1H)-pyrimidinedione), RS 17053 (N-[2(2-cyclopropylmethoxy) ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamide), and the selective alpha(1D)-adrenoceptor antagonist BMY 7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5] decane-7,9-dione). Results showed a 100-fold higher potency of A-61603 for the alpha(1)-adrenoceptor present in the artery, compared with phenylephrine. Prazosin displaced both agonists with high affinity, whereas 5-methylurapidil, RS 100329 and RS 17053 displaced A-61603 with high affinity, indicating the presence of alpha(1A)-adrenoceptors. The selective alpha(1A)-adrenoceptor antagonists blocked phenylephrine responses with low affinity, suggesting that phenylephrine activated a second receptor population in caudal artery. BMY 7378 antagonized with low affinity both A-61603 and phenylephrine-induced contractions, indicating absence of alpha(1D)-adrenoceptors in the vessel. The results suggest that functional alpha(1B)-adrenoceptors are present in caudal arteries of the young Wistar rat.

[1]  A. Pupo,et al.  Differential Distribution of Functional α1-Adrenergic Receptor Subtypes along the Rat Tail Artery , 2005, Journal of Pharmacology and Experimental Therapeutics.

[2]  D. Barettino,et al.  Correlation between mRNA levels and functional role of α1-adrenoceptor subtypes in arteries: evidence of α1L as a functional isoform of the α1A-adrenoceptor , 2005 .

[3]  James A. Slattery,et al.  Sympathectomy reveals α1A‐ and α1D‐adrenoceptor components to contractions to noradrenaline in rat vas deferens , 2004 .

[4]  M. Kunitomo,et al.  Alpha‐1D adrenoceptors are involved in reserpine‐induced supersensitivity of rat tail artery , 2004, British journal of pharmacology.

[5]  H. Pertz,et al.  Evidence that α1B-adrenoceptors are involved in noradrenaline-induced contractions of rat tail artery , 2004 .

[6]  R. Villalobos-Molina,et al.  Evidence for the role of α1D- and α1A-adrenoceptors in contraction of the rat mesenteric artery , 2003 .

[7]  M. Noguera,et al.  Functional evidence of a constitutively active population of alpha(1D)-adrenoceptors in rat aorta. , 2000, The Journal of pharmacology and experimental therapeutics.

[8]  J. Pediani,et al.  Quantitative imaging in live human cells reveals intracellular alpha(1)-adrenoceptor ligand-binding sites. , 2000, The Journal of pharmacology and experimental therapeutics.

[9]  R. Villalobos-Molina,et al.  Differential response to chloroethylclonidine in blood vessels of normotensive and spontaneously hypertensive rats: role of α1D‐ and α1A‐adrenoceptors in contraction , 2000 .

[10]  C. Han,et al.  Alpha(1)-adrenoceptor subtypes mediating inotropic responses in rat heart. , 1999, The Journal of pharmacology and experimental therapeutics.

[11]  J. Docherty,et al.  Investigation of the subtypes of α1‐adrenoceptor mediating contractions of rat vas deferens , 1999 .

[12]  J. Gever,et al.  In vitroα1‐adrenoceptor pharmacology of Ro 70–0004 and RS‐100329, novel α1A‐adrenoceptor selective antagonists , 1999 .

[13]  M. Oriowo,et al.  Heterogeneity of α1-Adrenoceptor Subtypes Mediating Noradrenaline-Induced Contractions of theRat Superior Mesenteric Artery , 1998, Pharmacology.

[14]  M. Piascik,et al.  Immunocytochemical localization of the alpha-1B adrenergic receptor and the contribution of this and the other subtypes to vascular smooth muscle contraction: analysis with selective ligands and antisense oligonucleotides. , 1997, The Journal of pharmacology and experimental therapeutics.

[15]  J. Docherty,et al.  Further investigation of the alpha-adrenoceptor-mediated actions of chloroethylclonidine in rat aorta. , 1997, European journal of pharmacology.

[16]  J. Gever,et al.  Pharmacological pleiotropism of the human recombinant α1A‐adrenoceptor: implications for α1‐adrenoceptor classification , 1997 .

[17]  R. Villalobos-Molina,et al.  Evidence for an age-dependent functional expression of α1D-adrenoceptors in the rat vasculature , 1997 .

[18]  R. Villalobos-Molina,et al.  α1D- and α1A-adrenoceptors mediate contraction in rat renal artery , 1997 .

[19]  A. Ford,et al.  Pharmacological characterization of an α1A‐adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat , 1997, British journal of pharmacology.

[20]  C. Chapple,et al.  Different subtypes of α1A‐adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053 , 1996, British journal of pharmacology.

[21]  L. Zhou,et al.  Vascular alpha 1D-adrenoceptors have a role in the pressor response to phenylephrine in the pithed rat. , 1996, European journal of pharmacology.

[22]  R. Villalobos-Molina,et al.  α1-Adrenoceptors mediating contraction in arteries of normotensive and spontaneously hypertensive rats are of the α1D or α1A subtypes , 1996 .

[23]  T. Stamey,et al.  RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification. , 1996, Molecular pharmacology.

[24]  M. S. Smith,et al.  The specific contribution of the novel alpha-1D adrenoceptor to the contraction of vascular smooth muscle. , 1995, The Journal of pharmacology and experimental therapeutics.

[25]  W. B. Jeffries,et al.  Quantification of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. , 1995, The Journal of pharmacology and experimental therapeutics.

[26]  A. Goetz,et al.  BMY 7378 is a selective antagonist of the D subtype of α1-adrenoceptors , 1995 .

[27]  I. Muramatsu,et al.  Two distinct α1‐adrenoceptor subtypes involved in noradrenaline contraction of the rabbit thoracic aorta , 1990, British journal of pharmacology.

[28]  K. Minneman Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+. , 1988, Pharmacological reviews.

[29]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.